Bioenergetics and oxidative phosphorylation

In short

Bioenergetics is the quantitative study of energy flow in living cells — how the free energy released by catabolism is captured, stored in ATP, and spent on biosynthesis, transport and motion. Oxidative phosphorylation is the final and largest ATP-making step: electrons stripped from food by NAD⁺ and FAD are passed down the inner-mitochondrial-membrane respiratory chain to O₂, and the energy released is stored as a proton gradient that drives ATP synthase. It is the highest-yield section of B.Sc Biochemistry metabolism papers and a guaranteed topic in CSIR-UGC NET (Life Sciences), GATE BT/XL, ICMR-JRF, DBT-BET and ICAR-NET. In industry it underpins mitochondrial-toxicity screening in pharma (Syngene, Biocon, Dr Reddy's, Sun Pharma), fermentation yield calculations, and clinical biochemistry of lactic acidosis and mitochondrial disorders (NIMHANS, AIIMS, CSIR-CCMB).

Explained

Thermodynamic basis

• Gibbs free energy change (ΔG) decides spontaneity at constant T and P: ΔG < 0 exergonic (spontaneous), ΔG > 0 endergonic, ΔG = 0 equilibrium.
• ΔG°′ is the standard free-energy change in biochemistry: 1 M solutes, 25 °C (298 K), 1 atm, pH 7.0, [H₂O] and [Mg²⁺] taken as constant. This pH-7 convention is what distinguishes ΔG°′ from the chemist's ΔG°.
• ΔG°′ is a constant for a reaction; ΔG is not — it depends on actual concentrations, so a reaction with positive ΔG°′ can still run forward if products are kept low.
• ΔG is additive: coupled reactions sum their ΔG values. This is the whole logic of metabolism — an unfavourable step is driven by coupling to ATP hydrolysis in a *shared intermediate* (not by mere simultaneity).
• Enthalpy–entropy split: ΔG = ΔH − TΔS. Hydrophobic collapse in protein folding is entropy-driven (water released); most oxidations are enthalpy-driven.
• Catabolism oxidises fuels and conserves energy as ATP, NADH, FADH₂ and NADPH; anabolism spends it. The cell is an open, steady-state (not equilibrium) system; equilibrium = death.

High-energy compounds and the ATP cycle

• ATP hydrolysis to ADP + Pi has ΔG°′ = −30.5 kJ/mol (≈ −7.3 kcal/mol); to AMP + PPi it is −45.6 kJ/mol. In the cell ΔG is about −50 to −55 kJ/mol because ATP ≫ ADP.
• Why ATP is "high-energy": electrostatic repulsion between four negative charges, resonance stabilisation of released Pi, greater solvation of products, and relief of strain — not a weak bond.
• ATP is an intermediate, not a store: a human turns over tens of kilograms of ATP a day with a standing pool of only about 50–100 g; the real store is creatine phosphate, glycogen and fat.
• Phosphoryl transfer potential (ΔG°′ of hydrolysis, kJ/mol): PEP −61.9 > carbamoyl phosphate −51.4 > 1,3-bisphosphoglycerate −49.3 > creatine phosphate −43.1 > ATP −30.5 > glucose-6-phosphate −13.8 > glycerol-3-phosphate −9.2. ATP sits deliberately mid-table so it can both accept and donate phosphoryl groups.
• Substrate-level phosphorylation (glycolysis steps 7 and 10, succinyl-CoA synthetase) makes ATP directly from a high-energy substrate — no membrane, no O₂ — unlike oxidative phosphorylation.
• Adenylate kinase: 2 ADP ⇌ ATP + AMP (K′ ≈ 1), lets AMP signal energy depletion; AMPK senses it.
• Energy charge (Atkinson) ranges 0–1 and is held near 0.85–0.95 in healthy cells.

Redox potentials and electron carriers

• Standard reduction potential E°′ is measured at pH 7, 25 °C against the hydrogen electrode. A more positive E°′ = greater electron affinity; electrons flow spontaneously from low to high E°′.
• Key values (V): NAD⁺/NADH −0.320; FMN/FMNH₂ (free) −0.219; fumarate/succinate +0.031; ubiquinone/ubiquinol +0.045; cyt b (+0.077); cyt c₁ +0.22; cyt c +0.254; cyt a +0.29; cyt a₃ +0.35; ½O₂/H₂O +0.816.
• Overall span NADH → O₂ = 0.816 − (−0.320) = 1.14 V, worth −220 kJ/mol of NADH.
• Carrier types: pyridine nucleotides (NAD⁺/NADP⁺, 2e⁻ + 1H⁺ as hydride, water-soluble, diffusible); flavins (FMN, FAD — tightly/covalently bound, can carry 1e⁻ or 2e⁻, hence semiquinone radical); iron–sulphur centres (2Fe-2S, 4Fe-4S, Rieske — 1e⁻ only, no protons); ubiquinone/CoQ (lipid-soluble, mobile in the bilayer, 2e⁻ + 2H⁺, so it *carries protons across*); cytochromes (haem iron, Fe³⁺/Fe²⁺, 1e⁻); copper centres (CuA, CuB in Complex IV).
• NAD⁺ is the catabolic oxidant; NADPH is the anabolic reductant (fatty-acid and steroid synthesis, glutathione reduction) — same chemistry, separate pools, different enzymes.

The electron transport chain: four complexes

Located in the inner mitochondrial membrane (cristae), which is impermeable to H⁺; the outer membrane is porous (porins).

1. Complex I — NADH:ubiquinone oxidoreductase (~45 subunits, 7 mtDNA-encoded): NADH + Q + 5H⁺(matrix) → NAD⁺ + QH₂ + 4H⁺(IMS). Prosthetic groups FMN + 8–9 Fe-S clusters. L-shaped; proton pumping is conformational. Inhibited by rotenone, piericidin A, amytal, metformin (partial).
2. Complex II — succinate dehydrogenase (4 subunits, all nuclear-encoded; the only TCA enzyme in the membrane): succinate + Q → fumarate + QH₂, via covalently bound FAD and Fe-S. Pumps no protons — hence FADH₂ yields less ATP. Inhibited by malonate, TTFA, carboxin.
3. Complex III — cytochrome bc₁ (dimeric): QH₂ + 2 cyt c(ox) + 2H⁺(matrix) → Q + 2 cyt c(red) + 4H⁺(IMS). Works by the Q cycle, which solves the mismatch between 2e⁻ quinone and 1e⁻ cytochrome c: at site Qo one electron goes down the high-potential chain (Rieske Fe-S → cyt c₁ → cyt c) and the other down the low-potential chain (cyt b_L → cyt b_H) to reduce a second quinone at Qi in two turns. Inhibited by antimycin A (Qi) and myxothiazol/stigmatellin (Qo).
4. Complex IV — cytochrome c oxidase: 4 cyt c(red) + O₂ + 8H⁺(matrix) → 4 cyt c(ox) + 2H₂O + 4H⁺(IMS) (i.e. 2H⁺ pumped per 2e⁻). Centres: CuA → haem a → binuclear haem a₃–CuB, where O₂ is reduced without releasing partially reduced intermediates. Inhibited by cyanide, carbon monoxide, azide, H₂S, NO.
5. Other entry points to the Q pool: glycerol-3-phosphate dehydrogenase, ETF:QO (fatty-acid β-oxidation), dihydroorotate dehydrogenase, choline dehydrogenase — all deliver at CoQ, bypassing Complex I.
6. Complex V is ATP synthase (below); complexes I, III, IV associate into supercomplexes (respirasomes) for substrate channelling.

Chemiosmotic theory and ATP synthase

• Peter Mitchell, 1961 (Nobel 1978): the link between oxidation and phosphorylation is not a chemical "high-energy intermediate" but an electrochemical proton gradient across a closed, topologically intact membrane.
• Postulates: (i) the chain pumps H⁺ vectorially outward; (ii) the membrane is H⁺-impermeable; (iii) the gradient (proton-motive force) is the energy currency; (iv) ATP synthase lets H⁺ back in and uses the flow to make ATP.
• Proton-motive force Δp has two parts: a membrane potential Δψ (~150–180 mV, matrix negative) and a pH difference (~0.5–0.75 unit, matrix alkaline). In mitochondria Δψ dominates; in chloroplasts ΔpH dominates.
• Classic evidence: Jagendorf and Uribe's acid-bath experiment (chloroplast thylakoids made ATP in the dark from an imposed pH jump); Racker and Stoeckenius reconstituted vesicles with bacteriorhodopsin + ATP synthase that made ATP on illumination; uncouplers abolish ATP synthesis without blocking electron flow; submitochondrial particles lose coupling when leaky.
• ATP synthase (F₁F₀, Complex V) — a rotary motor. F₁ (matrix side) = α₃β₃γδε, three catalytic β subunits; F₀ (membrane) = subunit a, b₂, and a ring of c subunits (8 in mammals, 10 in yeast, 8–15 across species). Rotor = c-ring + γε; stator = a + b₂ + δ (+ OSCP).
• Binding-change mechanism (Paul Boyer; structure by John Walker, Nobel 1997): the three β sites cycle through Open → Loose → Tight states as the asymmetric γ shaft rotates 120° per ATP; the energy of the proton gradient is used mainly to release the ATP, not to form the bond. One full 360° rotation = 3 ATP.
• H⁺ per ATP = c subunits ÷ 3 ≈ 2.7 in mammals, plus ~1 H⁺ equivalent for the ATP/ADP and phosphate exchanges, so the working figure is ~4 H⁺ per cytosolic ATP.
• Inhibitors: oligomycin and DCCD (block F₀ proton channel), aurovertin and efrapeptin (F₁). ATP synthase is reversible — it hydrolyses ATP to maintain Δψ in anoxia, which is why oligomycin protects dying tissue.
• Respiratory control: O₂ consumption is governed by ADP availability. Chance–Williams states 1–5; state 3 = ADP present, fast respiration; state 4 = ADP exhausted, slow. RCR = state 3 ÷ state 4 rate (healthy mitochondria > 4).

ATP yield, shuttles and transporters

• Current consensus P/O ratios: 2.5 ATP per NADH (10 H⁺ pumped ÷ 4) and 1.5 ATP per FADH₂ (6 H⁺ ÷ 4). Older textbooks say 3 and 2 — state which convention you are using in an exam.
• Glucose, complete oxidation: glycolysis 2 ATP + 2 NADH (cytosolic); PDH 2 NADH; TCA (2 turns) 6 NADH + 2 FADH₂ + 2 GTP → 30–32 ATP, consuming 6 O₂.
• Cytosolic NADH cannot cross the inner membrane; it is ferried by: malate–aspartate shuttle (heart, liver — delivers NADH to the matrix, 2.5 ATP) or glycerol-3-phosphate shuttle (skeletal muscle, brain — delivers to FAD, 1.5 ATP). Hence 32 vs 30.
• Translocases: adenine nucleotide translocase (ANT, ATP⁴⁻ out / ADP³⁻ in — electrogenic, inhibited by atractyloside, bongkrekic acid); phosphate translocase (H₂PO₄⁻ with H⁺); dicarboxylate, tricarboxylate (citrate–malate) and pyruvate carriers.
• Efficiency: aerobic glucose oxidation conserves ~34% of the 2,840 kJ/mol available; anaerobic glycolysis only 2 ATP per glucose but very fast — the basis of the Warburg effect and of muscle lactate.

Uncouplers, ROS, disease and applications

• Uncouplers are lipid-soluble weak acids that shuttle H⁺ across the membrane: 2,4-dinitrophenol (DNP), FCCP, CCCP, salicylate (high dose). Electron transport and O₂ uptake *increase*, ATP synthesis stops, energy appears as heat. DNP was sold as a slimming drug in the 1930s and is banned worldwide; in India its sale for human consumption is illegal under the Drugs and Cosmetics Act and FSSAI rules, and deaths from internet-sourced DNP are reported.
• Physiological uncoupling: thermogenin (UCP1) in brown adipose tissue generates non-shivering heat in newborns and hibernators.
• Ionophores differ from uncouplers: valinomycin (K⁺) collapses Δψ, nigericin (K⁺/H⁺) collapses ΔpH.
• ROS: 0.1–2% of electrons leak at Complex I (matrix) and Complex III (both sides) to give superoxide; defences are MnSOD/CuZnSOD → catalase and glutathione peroxidase (needs GSH, selenium), plus peroxiredoxin/thioredoxin, vitamins E and C, CoQ₁₀.
• mtDNA: 16,569 bp, maternally inherited, 13 OXPHOS proteins, 22 tRNA, 2 rRNA; no histones and limited repair → high mutation rate, heteroplasmy and threshold effect. Diseases: MELAS, MERRF, LHON, Leigh syndrome, NARP, Kearns–Sayre; also mitochondrial permeability transition and cytochrome c release triggering apoptosis.
• Poisons and antidotes in practice: cyanide (from industrial effluent, apricot/cassava) treated with hydroxocobalamin or sodium nitrite + thiosulphate; CO poisoning with 100% O₂. Both block Complex IV, so tissues cannot use O₂ despite normal blood saturation.
• Pharma use: mitochondrial-toxicity screening (Seahorse XF oxygen-consumption and extracellular-acidification assays, JC-1 membrane-potential dye) is a standard early-safety panel in Indian CRO/CDMO labs; drug-induced OXPHOS inhibition explains hepatotoxicity of some antiretrovirals and of overdosed metformin (lactic acidosis).

Key points

• ΔG°′ – standard free-energy change at pH 7, 25 °C, 1 M; a constant, unlike ΔG.
• ATP hydrolysis – ΔG°′ = −30.5 kJ/mol; actual cellular ΔG ≈ −50 kJ/mol.
• Coupling – an endergonic step is driven only through a *shared intermediate* with an exergonic one.
• Phosphoryl transfer potential – ATP is mid-range by design: PEP and creatine phosphate above it, sugar phosphates below.
• E°′ – more positive means stronger electron acceptor; electrons flow NADH (−0.32 V) → O₂ (+0.816 V), span 1.14 V.
• Complex I – NADH → CoQ, FMN + Fe-S, pumps 4 H⁺, blocked by rotenone.
• Complex II – succinate → CoQ, FAD, pumps no protons, all nuclear-encoded.
• Complex III – Q cycle, CoQ → cyt c, pumps 4 H⁺, blocked by antimycin A.
• Complex IV – cyt c → O₂ via haem a₃–CuB, pumps 2 H⁺, blocked by cyanide and CO.
• H⁺ stoichiometry – 10 H⁺ per NADH, 6 H⁺ per FADH₂; ~4 H⁺ consumed per ATP exported.
• Chemiosmotic theory – Mitchell 1961; the coupling intermediate is the proton-motive force, not a chemical compound.
• Δp – Δψ (~150–180 mV) plus ΔpH (~0.5–0.75); matrix negative and alkaline.
• ATP synthase – F₁ (α₃β₃γδε) + F₀ (ab₂c₈₋₁₅); rotary, binding-change mechanism, 3 ATP per revolution.
• P/O ratio – 2.5 for NADH, 1.5 for FADH₂; glucose gives 30–32 ATP.
• Shuttles – malate–aspartate (2.5 ATP) vs glycerol-3-phosphate (1.5 ATP) for cytosolic NADH.
• Uncoupler vs inhibitor – uncouplers raise O₂ uptake and kill ATP output; inhibitors stop both.
• Respiratory control – ADP availability sets the respiration rate; RCR > 4 indicates intact mitochondria.
• ROS – leak at Complexes I and III; handled by SOD, catalase, glutathione peroxidase.

Formulas and examples

Example 1 — energy available from one NADH, and the efficiency of its conservation. ΔE°′ = +0.816 − (−0.320) = 1.136 V; n = 2. ΔG°′ = −2 × 96.485 × 1.136 = −219.2 kJ/mol. Conserved as 2.5 ATP × 30.5 = 76.25 kJ → efficiency = 76.25/219.2 = 34.8%. For FADH₂ via succinate: ΔE°′ = 0.816 − 0.031 = 0.785 V → ΔG°′ = −2 × 96.485 × 0.785 = −151.5 kJ/mol; 1.5 ATP = 45.75 kJ → 30.2%.

Example 2 — actual ΔG of ATP hydrolysis in a cell. Take [ATP] = 5 mM, [ADP] = 0.5 mM, [Pi] = 5 mM, T = 310 K. Ratio = ([ADP][Pi])/[ATP] = (5×10⁻⁴ × 5×10⁻³)/(5×10⁻³) = 5×10⁻⁴. ln(5×10⁻⁴) = −7.601; RT ln(...) = 2.577 × (−7.601) = −19.6 kJ/mol. ΔG = −30.5 − 19.6 = −50.1 kJ/mol — much more negative than ΔG°′, because the cell holds ATP far from equilibrium.

Example 3 — is the proton-motive force enough to make ATP? Δψ = 0.16 V, ΔpH = 0.75 (matrix alkaline), T = 310 K. ΔG per mol H⁺ = (96.485 × 0.16) + (5.94 × 0.75) = 15.44 + 4.46 = 19.9 kJ/mol H⁺. With ~4 H⁺ per ATP: 4 × 19.9 = 79.6 kJ, against ~50–55 kJ needed. Yes — with margin, which is why ATP synthesis continues even when the gradient falls. (Δp as a voltage = 160 + (0.75 × 61.5 mV per pH unit at 310 K) → 160 + 46 = 206 mV.)

Example 4 — P/O ratio from an oxygraph trace. Isolated liver mitochondria + glutamate/malate; a pulse of 120 nmol ADP causes a state-3 burst consuming 24 nmol O₂. ng-atom O = 2 × 24 = 48 ng-atom. ADP/O = 120/48 = 2.5 → consistent with NADH-linked substrate. If the trace had been run on succinate and 120 nmol ADP consumed 40 nmol O₂ (80 ng-atom O), ADP/O = 120/80 = 1.5 — FADH₂-linked, as expected. State-3 rate 90 nmol O₂/min, state-4 rate 15 → RCR = 6.0 (well coupled). Adding DNP would make the rate maximal and RCR collapse to ~1.

Example 5 — K′eq of the creatine kinase reaction. Creatine phosphate + ADP → creatine + ATP: ΔG°′ = (−43.1) − (−30.5) = −12.6 kJ/mol. ln K′ = 12.6/2.577 = 4.889 → K′ = e⁴·⁸⁸⁹ ≈ 133 at 310 K — strongly forward, so creatine phosphate is an effective instant ATP buffer in muscle.

Example 6 — ATP ledger for one glucose and overall efficiency.

With the glycerol-3-phosphate shuttle the 2 cytosolic NADH yield 1.5 each → 30 ATP. Efficiency = 32 × 30.5 = 976 kJ out of 2,840 kJ/mol glucose = 34.4%.

Where it is used

• Pharmaceutical safety and discovery (Syngene, Biocon, Dr Reddy's, Sun Pharma, Aurigene, ICMR/NIPER labs): mitochondrial-toxicity panels — oxygen consumption rate, membrane potential, ATP content — as part of preclinical hepatotoxicity screening; OXPHOS inhibitors are also an oncology target.
• Clinical biochemistry and neurology (AIIMS, NIMHANS, CMC Vellore, SGPGI): lactate/pyruvate ratio, CK, blood gas interpretation in lactic acidosis; muscle-biopsy respiratory-chain enzyme assays and mtDNA sequencing for MELAS/LHON/Leigh; cyanide and CO poisoning management in emergency medicine.
• Fermentation and biotech process roles: aerobic vs anaerobic ATP yield sets biomass yield coefficients and aeration/agitation design in antibiotic, enzyme and ethanol plants (Biocon, Praj, Serum Institute upstream teams); Crabtree/Warburg effects govern feeding strategy.
• Nutrition, sports science and public health: creatine phosphate and glycolytic vs oxidative ATP supply in training; thiamine, riboflavin, niacin, iron and CoQ₁₀ status directly affect chain function; FSSAI-regulated supplement claims.
• Agrochemicals and toxicology: rotenone (Complex I), carboxin (Complex II), strobilurin fungicides (Complex III) and cyanide-releasing compounds — relevant to pesticide registration under the Insecticides Act, 1968 and the Central Insecticides Board, and to residue/poisoning case work in FSL laboratories.
• Academic and teaching posts, CSIR-CCMB/IISc/NCBS research: mitochondrial bioenergetics, ROS signalling, ageing and apoptosis are active Indian research lines; Seahorse and Clark-electrode/oxygraph skills are listed in JRF advertisements.

Interview questions

• Q: Why is ATP called a high-energy compound when its bonds are ordinary covalent bonds? A: The large negative ΔG°′ comes from relief of charge repulsion among its phosphates, resonance stabilisation and better solvation of the products — not from an unusually weak bond.
• Q: State the chemiosmotic hypothesis in one sentence. A: Mitchell proposed that electron transport pumps protons across an intact, H⁺-impermeable inner membrane, and the resulting electrochemical proton gradient — not a chemical intermediate — drives ATP synthesis by ATP synthase.
• Q: Why does FADH₂ give fewer ATP than NADH? A: It enters at CoQ, bypassing Complex I, so only 6 H⁺ are pumped instead of 10 — giving a P/O of 1.5 against 2.5.
• Q: How do you distinguish an uncoupler from an electron-transport inhibitor experimentally? A: An uncoupler raises O₂ consumption while abolishing ATP synthesis; an inhibitor reduces both. Adding DNP after oligomycin restores respiration; adding it after cyanide does not.
• Q: A patient has normal arterial O₂ saturation but severe lactic acidosis after a chemical exposure. What is likely? A: Cytochrome c oxidase inhibition by cyanide or hydrogen sulphide — oxygen is delivered but cannot be used, so cells switch to anaerobic glycolysis.
• Q: What is the purpose of the Q cycle? A: It reconciles two-electron ubiquinol with one-electron cytochrome c and doubles the protons translocated per pair of electrons through Complex III.
• Q: Why does ADP stimulate mitochondrial respiration? A: ATP synthase can only turn when its substrate ADP is available; proton re-entry then lowers the gradient's back-pressure and lets the pumps run faster — respiratory control.
• Q: Which respiratory complex is encoded entirely by nuclear DNA, and why does that matter clinically? A: Complex II; so its deficiencies follow Mendelian, not maternal, inheritance.
• Q: A reaction has ΔG°′ = +15 kJ/mol. Can it occur in a cell? A: Yes — if the product/substrate ratio is kept low enough, or if it is coupled through a common intermediate to ATP hydrolysis, the actual ΔG becomes negative.
• Q: How many protons does ATP synthase need per ATP, and why is it not a whole number? A: About 2.7 for the enzyme itself (8 c-subunits ÷ 3 catalytic sites in mammals), rising to roughly 4 per *cytosolic* ATP once the electrogenic ADP/ATP and phosphate exchanges are counted.
• Q: What does brown adipose tissue reveal about oxidative phosphorylation? A: UCP1 deliberately uncouples it, so substrate oxidation produces heat instead of ATP — proving that proton leak and ATP synthesis compete for the same gradient.
• Q: Why is P/O 2.5 rather than the textbook 3? A: Measured H⁺ stoichiometries (10 per NADH) and the c-ring count plus transport costs (~4 H⁺ per ATP) give 2.5; the older value assumed integral coupling sites.

Common mistakes

• Treating ΔG°′ and ΔG as interchangeable, and declaring a reaction impossible because ΔG°′ is positive.
• Writing ΔG°′ = −nFΔE°′ with the wrong n, or with ΔE°′ reversed — always subtract donor potential from acceptor potential and check that a spontaneous reaction gives a negative ΔG.
• Saying Complex II pumps protons, or putting ATP synthase in the "chain" as a fifth electron carrier.
• Confusing uncouplers with inhibitors, and with ionophores (valinomycin removes Δψ only; nigericin removes ΔpH only).
• Omitting the shuttle step for cytosolic NADH and then arguing about 36 vs 38 ATP using obsolete P/O ratios without stating the convention.
• Mixing units — kJ with kcal, mV with V, nmol O₂ with ng-atom O (factor of 2) — in bioenergetics numericals.
• Claiming the gradient's energy is used to form the phosphoanhydride bond; in the binding-change mechanism it is mainly used to release the bound ATP.
• Calling the outer mitochondrial membrane the proton barrier — it is freely permeable through porins; the inner membrane is the barrier.

Related topics

Biochemistry: biomolecules and enzymes · Enzyme kinetics · Glycolysis and the citric acid cycle · Photosynthesis and photophosphorylation · Membrane transport and ion gradients · Free radicals, antioxidants and oxidative stress